Albemarle announces Q3 2026 results as stock rises 3%

Albemarle announces Q3 2026 results as stock rises 3%
Albemarle stock rises 3% to $97.91

Albemarle Corp announced its 2026 third-quarter results. The stock is up 3% on the day at $97.91.

ALB price prediction
24H 0.19%
$88.33
48H -0.43%
$87.78
7D -1.74%
$86.63
1M -0.56%
$87.67
3M 48.37%
$130.8
6M 83.97%
$162.19
12M 8.28%
$95.46
Current price: $88.16 -5.3600 5.73%
Closed 11/16
Daily range 87.80 Arrow from to Icon 90.57
Weekly range 87.80 Arrow from to Icon 97.23
Loading...

Highlights

  • Albemarle projects 2026 capital spending between $300 million and $350 million, confirming operational investment plans for the year.
  • 53 of 89 analysts rate Albemarle stock a buy, and the median price target of $170 stands 73.6% above the current price.
  • Shares of Albemarle are up 3% on the day at $97.91.

Albemarle Corp announced its results for the third quarter of 2026. The company now expects its full-year 2026 capital expenditures to be between $300 million and $350 million, according to PR Newswire. Of the 89 analysts covering the stock, 53 rate it a buy, with none recommending a sell.

Upside capped as shares reclaim MA-20 amid overbought signals

Price reclaimed the MA-20 at $95.59 during the session, reversing its previous close below that level. The daily structure is split, with shares trading below both the MA-50 and MA-200 yet holding above the MA-20. The nearest resistance is now the Ichimoku Kijun at $98.71. Stoch RSI is in overbought territory, which limits further upside for now.

Odds favor further downside as price retests key support

Traders should watch for a close above $98.71 to confirm buyers are willing to follow through. Earlier, the price moved back above the MA-20 at $95.59 after slipping below it the previous day. Over the next five trading days, the probability of further downside stands at 67%, with only a 33% chance of upside, and shares are expected to trade between $95.21 and $100.6. Still, a drop below $95.81 would show the move is being faded. On the weekly chart the longer-term picture stays negative.

Earlier, analysts noted that Albemarle was under sustained bearish technical pressure despite intermittent rebounds. The latest quarterly results shift the focus to near-term resistance at $98.71, with a close above this level needed to challenge the prevailing downside risk and establish a more constructive trend.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.